Midori Ishikawa

638 citations
11 papers · 563 indexed · h-index 11
Topics
Venomous Animal Envenomation and Studies (3 papers)Blood Coagulation and Thrombosis Mechanisms (3 papers)Cell death mechanisms and regulation (2 papers)
Partner nations
Japan

In The Last Decade

Midori Ishikawa

11 papers receiving 537 citations

Peers

Midori Ishikawa
Comparison fields: 5 of 87
  • Molecular Biology 234
  • Organic Chemistry 116
  • Genetics 113
  • Oncology 110
  • Epidemiology 98
Replace Junhai Xiao with:
Junhai Xiao China
Juan Pablo Maianti Canada
Tam Dang United States
Ellene H. Mashalidis United States
KellyAnn D. Pryor United States
Fatma Guettou Sweden
Bernardo Ochoa‐Montaño United Kingdom
Kathleen M. McKenzie United States
Guus B. Erkens Netherlands
Masakatsu Kaneko Japan
Midori Ishikawa relative to Junhai Xiao China Junhai Xiao's profile →
Citations per field
00.5×7.1×
Junhai Xiao · 1×
Citations per year

Countries citing papers authored by Midori Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Midori Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midori Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midori Ishikawa more than expected).

Fields of papers citing papers by Midori Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Midori Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midori Ishikawa. The network helps show where Midori Ishikawa may publish in the future.

Co-authorship network of co-authors of Midori Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Midori Ishikawa. A scholar is included among the top collaborators of Midori Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midori Ishikawa. Midori Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 10
2 14
3 47
4 61
5 90
6 51
7 63
8 121
9 38
10 42
11 26

About Midori Ishikawa

Midori Ishikawa is a scholar working on Molecular Medicine, Hematology and Toxicology, having authored 11 papers that have together received 563 indexed citations. Recurring topics across this work include Venomous Animal Envenomation and Studies (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Molecular Medicine (63 citations), Microbiology (58 citations) and Physiology (20 citations). Midori Ishikawa has collaborated with scholars based in Japan. Frequent co-authors include Hideko Atoda, Hidemitsu Nakajima, Takashi Morita, Hiroshi Mizuno, Satoshi Yoshida, Kokichi Suzuki, Yasuo Satô, Shigeru Hoshiko, Toyokazu Hiranuma and Yumi Osaki. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026